Tri Locum Partners

Tri Locum Partners as of Sept. 30, 2024

Portfolio Holdings for Tri Locum Partners

Tri Locum Partners holds 20 positions in its portfolio as reported in the September 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Pfizer (PFE) 12.0 $50M 1.7M 28.94
Teva Pharmaceutical Inds Sponsored Ads (TEVA) 11.9 $50M 2.8M 18.02
Natera (NTRA) 9.7 $40M 317k 126.95
Stevanato Group S P A Ord Shs (STVN) 9.0 $37M 1.9M 20.00
Argenx Se Sponsored Adr (ARGX) 8.1 $34M 63k 542.08
Inspire Med Sys (INSP) 7.7 $32M 151k 211.05
Vaxcyte (PCVX) 7.4 $31M 272k 114.27
Avadel Pharmaceuticals Com Shs (AVDL) 5.2 $22M 1.7M 13.12
United Therapeutics Corporation (UTHR) 4.7 $20M 55k 358.35
Legend Biotech Corp Sponsored Ads (LEGN) 4.2 $18M 362k 48.73
Verona Pharma Sponsored Ads (VRNA) 4.1 $17M 594k 28.77
Insmed Com Par $.01 (INSM) 2.5 $11M 144k 73.00
Biohaven (BHVN) 2.3 $9.7M 193k 49.97
Merus N V (MRUS) 2.3 $9.6M 192k 49.96
Mind Medicine Mindmed Com New (MNMD) 2.3 $9.5M 1.7M 5.69
Madrigal Pharmaceuticals (MDGL) 2.2 $9.2M 43k 212.22
Axsome Therapeutics (AXSM) 2.0 $8.2M 92k 89.87
Novo-nordisk A S Adr (NVO) 1.9 $8.0M 67k 119.07
Korro Bio (KRRO) 0.5 $2.1M 64k 33.42
Femasys (FEMY) 0.0 $34k 31k 1.11